Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2016-05-05 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于对部分暂时闲置募集资金及自有资金进行现金管理的实施公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of temporarily idle raised funds and its own funds for cash management through purchasing bank wealth management products. It details the amounts, terms, expected returns, risk control measures, and impact on operations. The document is a formal public disclosure about financing activities related to cash management of idle funds, not a financial report or earnings release. It does not contain financial statements or quarterly/yearly results. It is not a report publication announcement since it contains substantive information about the cash management activities. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and use of funds.
2016-05-05 Chinese
独立董事关于第二届董事会第十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the company's board meeting, including election and appointment of senior management and their remuneration. It references compliance with company law and internal governance rules. The content focuses on board/management decisions rather than financial results or regulatory filings. The document length is short and it is not a report or announcement of a report. Therefore, it fits best under Board/Management Information (MANG).
2016-05-04 Chinese
第二届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of decisions made at a board meeting, including election and appointment of senior management positions such as vice chairman, general manager, and board secretary, as well as an adjustment to a senior executive's salary. It does not contain financial statements or detailed financial data. The focus is on changes in the company's board and senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2016-05-04 Chinese
关于董事会秘书辞职及新聘董事会秘书的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's board secretary and the appointment of a new board secretary. It includes details about the resignation, the appointment process, and the qualifications of the new secretary. There are no financial statements, earnings data, or detailed reports. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2016-05-04 Chinese
关于选举副董事长及总经理辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new vice chairman and the resignation of the general manager of the company. It includes details about the board meeting decisions, the individual's qualifications, and a resume attachment. There is no financial data, no mention of financial results, no regulatory filings, or report publications. The content focuses on changes in the company's board and senior management positions. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2016-05-04 Chinese
关于聘任公司总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new general manager (秦德超) at 普莱柯生物工程股份有限公司. It includes details about the board's approval, the individual's qualifications, and a brief biography. There is no financial data, no mention of financial results, reports, or regulatory filings. The content clearly relates to a change in senior management. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is short and focused solely on management appointment, confirming this classification.
2016-05-04 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.